T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS

{
  "signal_id": "4d824a62-e9d1-21cc-9d72-1a04631d630f",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-09-17T13:58:00+00:00",
  "company": {
    "name": "T. Rowe Price",
    "domain": "troweprice.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/t-rowe-price-debuts-biotech-small-cap-and-mid-cap-exchange-traded-funds-302882169.html",
    "title": "T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS",
    "excerpt": "Continuing steady expansion of its ETF lineup, the firm adds three new active equity offerings BALTIMORE , Sept. 17, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of three new equity exchange traded funds (ETFs): T. Rowe Price Biotech ETF (Ticker: TDNA); T. Rowe Price Small-Cap ETF (Ticker: TSEE); and T. Rowe Price Mid-Cap Equity Research ETF (Ticker: TMID). All three fully transparent actively managed ETFs began trading on the NASDAQ today. With today's launches, the firm has added eight new active exchange traded offerings to its roster this year, contributing to a total of 38 funds in the lineup. Today's additions broaden investors' access to more segments of the equity market and market themes. The T. Rowe Price Biotech ETF seeks long-term capital growth by identifying biotechnology companies and emerging technologies with the potential to have an outsized impact on treating and curing disease and improving the quality of human life. The fund is managed by John Hall, who has 11 years of investment experience all at T. Rowe Price. TDNA is expected to hold approximately 60-120 companies, and its expense ratio is 0.55%. The T. Rowe Price Small-Cap ETF is designed to provide diversified exposure to the U.S. small-cap equity market. It leverages the firm's heritage and experience in active...",
    "product": "T. Rowe Price Mid-Cap Equity Research ETF",
    "summary": "T. Rowe Price launched the T. Rowe Price Mid-Cap Equity Research ETF (TMID), a new active equity exchange-traded fund.",
    "location": "Baltimore, Maryland, USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS679616/T-Rowe-Price-Logo.jpg?id=OA2954093&p=facebook",
    "confidence": 0.9,
    "product_data": {
      "name": "T. Rowe Price Mid-Cap Equity Research ETF",
      "full_text": "T. Rowe Price Mid-Cap Equity Research ETF (Ticker: TMID)",
      "fuzzy_match": false
    },
    "product_tags": [
      "online_technology",
      "general_technology"
    ],
    "published_at": "2026-09-17T13:58:00Z",
    "location_data": [
      {
        "city": "Baltimore",
        "state": "Maryland",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-17",
    "article_sentence": "T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of three new equity exchange traded funds (ETFs): T. Rowe Price Biotech ETF (Ticker: TDNA); T. Rowe Price Small-Cap ETF (Ticker: TSEE); and T. Rowe Price Mid-Cap Equity Research ETF (Ticker: TMID)."
  }
}

curl https://signals.autobound.ai/v1/signals/4d824a62-e9d1-21cc-9d72-1a04631d630f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"troweprice.com","limit":20}'